Shenzhen - Delayed Quote CNY
Huapont Life Sciences Co.,Ltd. (002004.SZ)
4.1000
+0.0400
+(0.99%)
At close: 3:04:18 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,570,149.4474
11,664,669.7838
11,594,590.4163
13,232,365.5680
12,431,125.5073
Cost of Revenue
7,598,676.5448
7,683,859.3599
7,059,524.4290
7,874,067.7796
7,682,257.1934
Gross Profit
3,971,472.9026
3,980,810.4239
4,535,065.9873
5,358,297.7884
4,748,868.3139
Operating Expense
2,698,608.5945
2,709,607.3319
3,032,172.0715
3,350,046.0810
3,130,007.7375
Operating Income
1,272,864.3081
1,271,203.0919
1,502,893.9159
2,008,251.7074
1,618,860.5764
Net Non Operating Interest Income Expense
-280,086.3420
-299,846.6195
-277,276.7278
-360,738.1990
-407,189.5578
Pretax Income
-134,442.0912
-160,507.1833
892,387.5832
1,622,695.5224
1,281,246.2715
Tax Provision
181,781.9009
182,086.3736
215,455.6878
495,488.2388
361,041.7151
Net Income Common Stockholders
-270,209.4027
-298,989.9171
302,122.0265
433,483.5340
667,809.4394
Basic EPS
-0.14
-0.15
0.15
0.22
0.34
Diluted EPS
-0.14
-0.15
0.15
0.22
0.34
Basic Average Shares
1,973,467.4940
1,974,834.3270
1,979,829.7940
1,980,281.1050
1,979,867.8900
Diluted Average Shares
1,973,467.4940
1,974,834.3270
1,979,829.7940
1,980,281.1050
1,979,867.8900
Total Operating Income as Reported
-102,896.4217
-127,435.0072
926,511.2234
1,644,999.7021
1,333,641.4915
Total Expenses
10,297,285.1393
10,393,466.6919
10,091,696.5004
11,224,113.8605
10,812,264.9309
Net Income from Continuing & Discontinued Operation
-270,209.4027
-298,989.9171
302,122.0265
433,483.5340
667,809.4394
Normalized Income
305,578.4555
418,401.3777
569,991.3535
848,361.9773
772,883.6872
Interest Income
66,070.8574
69,659.9125
85,226.2544
87,958.2469
80,856.5242
Interest Expense
335,749.1128
349,974.1055
343,699.5977
434,012.3894
461,675.3200
Net Interest Income
-280,086.3420
-299,846.6195
-277,276.7278
-360,738.1990
-407,189.5578
EBIT
201,307.0217
189,466.9223
1,236,087.1809
2,056,707.9117
1,742,921.5914
EBITDA
201,307.0217
1,158,509.7998
2,127,322.5319
2,856,936.9751
2,490,604.9651
Reconciled Cost of Revenue
7,598,676.5448
7,683,859.3599
7,059,524.4290
7,874,067.7796
7,682,257.1934
Reconciled Depreciation
--
969,042.8775
891,235.3510
800,229.0634
747,683.3737
Net Income from Continuing Operation Net Minority Interest
-270,209.4027
-298,989.9171
302,122.0265
433,483.5340
667,809.4394
Total Unusual Items Excluding Goodwill
-959,646.4303
-956,521.7265
-353,127.4903
-597,247.1986
-146,300.0670
Total Unusual Items
-959,646.4303
-956,521.7265
-353,127.4903
-597,247.1986
-146,300.0670
Normalized EBITDA
1,160,953.4520
2,115,031.5262
2,480,450.0222
3,454,184.1737
2,636,905.0321
Tax Rate for Calcs
0.0004
0.0003
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-383,858.5721
-239,130.4316
-85,258.1633
-182,368.7553
-41,225.8192
12/31/2021 - 6/25/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EACTF Earth Alive Clean Technologies Inc.
0.0005
0.00%
4955.T
001231.SZ Norsyn Crop Technology Co., Ltd.
18.59
+2.09%
000953.SZ Guangxi Hechi Chemical Co., Ltd
5.91
+3.87%
300387.SZ Hubei Forbon Technology Co.,Ltd.
8.39
+2.82%
600796.SS Zhejiang Qianjiang Biochemical Co., Ltd
5.58
+2.39%
000912.SZ Sichuan Lutianhua Company Limited By Shares
4.8600
+0.62%
600470.SS LIUGUO CHEMICAL
5.21
+3.37%
002513.SZ Jiangsu Lanfeng Bio-chemical Co.,Ltd
4.5600
+6.54%
000731.SZ Sichuan Meifeng Chemical Industry Co., Ltd.
6.79
+1.34%